Sonoma Pharmaceuticals (SNOA) Shares Outstanding (Diluted) (2013 - 2026)
Sonoma Pharmaceuticals (SNOA) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 833.33 Mn |
| 10 | Sonoma Pharmaceuticals | 5.15 Mn | -184,359.87 | 2.58 Mn | 3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.85 Mn |
| Mar 31, 2026 | 1.68 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 851,450.00 |
| Mar 31, 2024 | 454,500.00 |
| Dec 31, 2023 | 545,450.00 |
| Sep 30, 2023 | 258.00 |
| Jun 30, 2023 | 247.00 |
| Mar 31, 2023 | 170.00 |
| Dec 31, 2022 | 155.00 |
| Sep 30, 2022 | 155.00 |
| Jun 30, 2022 | 155,050.00 |
| Mar 31, 2022 | 133.00 |
| Dec 31, 2021 | 154.00 |
| Sep 30, 2021 | 117,200.00 |